Frontiers in oncology

SULT1A1 controls osteosarcoma cell growth and how melatonin slows tumor growth at a key cell development stage

Updated

Abstract

Circadian disruption is increasingly recognized as a factor in tumor development.

  • Circadian genes may play a role in determining the fate of osteosarcoma cells.
  • The influence of circadian disruption on therapeutic responses in osteosarcoma is not yet fully understood.
  • Further investigation is needed to clarify the relationship between circadian rhythms and tumor evolution.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

No commercial or financial ties reported.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free